XtalPi

aid: xtalpi
name: XtalPi
description: XtalPi is an AI-and-quantum-physics drug discovery and materials research platform company with headquarters
  in Cambridge, Massachusetts and major operations in Beijing, Shanghai, and Shenzhen, publicly listed on the Hong Kong Stock
  Exchange under stock code 2228.HK. The company combines a hybrid AI plus quantum mechanics (QM) discovery engine with large-scale
  robotic laboratory automation to accelerate molecular research and development for pharmaceutical, agrochemical, and materials
  customers, including engagements with Pfizer, Eli Lilly, and Novartis. XtalPi's offering spans proprietary software platforms
  — PatSight for patent extraction, XFEP for free-energy perturbation binding-affinity prediction, XMolGen for generative
  chemistry, and XtalGazer for solid-state research — and intelligent automation hardware including the XmartChem intelligent
  synthesis workstation and ChemPlus desktop solid dispenser. Its drug discovery services cover hit discovery, hit/lead optimization,
  biology capabilities, focused library synthesis, and the PepiX peptide platform, complemented by sister brands Ailux (biology)
  and AiFChem (chemistry). XtalPi's products are delivered as enterprise collaborations, licensed software, and CRO-style
  services; there is no public developer API, SDK, or open-source release.
type: Index
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
position: Provider
access: 3rd-Party
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/xtalpi.png
tags:
- Drug Discovery
- Pharmaceutical Research
- AI Drug Discovery
- Quantum Mechanics
- Quantum Physics
- Computational Chemistry
- Generative Chemistry
- Molecular Simulation
- Free Energy Perturbation
- Solid-State Research
- Peptide Therapeutics
- Lab Automation
- Intelligent Laboratories
- Robotics
- Materials Science
- Life Sciences
- Biotechnology
url: https://raw.githubusercontent.com/api-evangelist/xtalpi/refs/heads/main/apis.yml
created: '2026-05-24'
modified: '2026-05-24'
specificationVersion: '0.20'
apis: []
common:
- type: DomainSecurity
  url: security/xtalpi-domain-security.yml
- type: Website
  url: https://en.xtalpi.com/
- type: About
  url: https://en.xtalpi.com/about/
- type: Technology
  url: https://en.xtalpi.com/technology/
- type: DigitalChemistry
  url: https://en.xtalpi.com/digital-chemistry/
- type: DrugDiscovery
  url: https://en.xtalpi.com/drug-discovery/
- type: PatSight
  url: https://en.xtalpi.com/patsight/
- type: XFEP
  url: https://en.xtalpi.com/xfep/
- type: XMolGen
  url: https://en.xtalpi.com/xmolgen/
- type: XtalGazer
  url: https://www.xtalgazer.com/
- type: ChemicalSynthesis
  url: https://en.xtalpi.com/chemical-synthesis
- type: FocusedLibrary
  url: https://en.xtalpi.com/focused-library/
- type: HitDiscovery
  url: https://en.xtalpi.com/hit-discovery/
- type: HitOrLeadOptimization
  url: https://en.xtalpi.com/hit-or-lead-optimization/
- type: BiologyCapabilities
  url: https://en.xtalpi.com/biology-capabilities/
- type: PepiX
  url: https://en.xtalpi.com/pepix/
- type: Ailux
  url: https://ailuxbio.com/
- type: AiFChem
  url: https://www.aifchem.com/
- type: Resources
  url: https://en.xtalpi.com/resources/
- type: News
  url: https://en.xtalpi.com/category/news/
- type: InvestorRelations
  url: https://ir.xtalpi.com/en/
- type: Careers
  url: https://hire-r1.mokahr.com/social-recruitment/XtalPi/100000047#/jobs
- type: Contact
  url: https://en.xtalpi.com/contact-us
- type: GitHub
  url: https://github.com/xtalpi
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com